The national institute of occupational safety and health has identified which of the following

Índice Show

What has the National Institute for Occupational Safety and Health identified as hazardous drugs?
What are the categories of hazardous medications?
Where would you find warnings and special handling for hazardous drugs?
What is NIOSH quizlet?

Sept 2016DHHS (NIOSH) Publication Number 2016-161 (Supersedes 2014-138)

The National Institute for Occupational Safety and Health (NIOSH) Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings was published in September 2004. In Appendix A of the Alert, NIOSH identified a sample list of major hazardous drugs. The list was compiled from information provided by four institutions that had generated lists of hazardous drugs for their respective institutions, as well as a list from the Pharmaceutical Research and Manufacturers of America (PhRMA). The 2004 list was updated in 2010, 2012 and 2014. A new format was developed for the 2014 list of hazardous drugs, as described below. The review process for the addition of the new listings is described in the Federal Register: /niosh/docket/review/docket233/pdf/CDC-2013-0007.pdfpdf icon.

The current update (2016) adds 34 drugs and includes a review of the 2004 list. The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) has updated its list of hazardous drugs for 2016. This list includes drugs reviewed by NIOSH from January 2012 to December 2013. Additional information for the 2016 update can be found at: Federal Register Noticepdf icon

March 23, 2022
The manufacturers of trabectedin (Yondelis®), inotuzumab ozogamicin (Besponsa™), polatuzumab vedotin (Polivy™), enfortumab vedotin (Padcev™), trastuzumab deruxtecan (Enhertu®), sacituzumab govitecan (Trodelvy™), loncastuximab tesirine (Zynlonta™), melphalan flufenamide (Pepaxto®), belantamab mafodotin (Blenrep), and tisotumab vedotin-tftv (Tivdak™) recommend that they be handled as hazardous drugs. Therefore, NIOSH considers these drugs to be included in Table 1 of the NIOSH list of hazardous drugs. For additional information, see the package inserts for these drugs.

NIOSH list of hazardous drugs

Drug	AHFS Classification	Links	Date Approved
trabectedin (Yondelis®)	10:00 Antineoplastic Agents	DailyMedexternal icon	October 23, 2015
inotuzumab ozogamicin (Besponsa™)	10:00 Antineoplastic Agents	DailyMedexternal icon	August 17, 2017
polatuzumab vedotin (Polivy™)	10:00 Antineoplastic Agents	DailyMedexternal icon	June 10, 2019
enfortumab vedotin (Padcev™)	10:00 Antineoplastic Agents	DailyMedexternal icon	December 18,2019
trastuzumab deruxtecan (Enhertu®)	10:00 Antineoplastic Agents	DailyMedexternal icon	December 20, 2019
sacituzumab govitecan (Trodelvy™)	10:00 Antineoplastic Agents	DailyMedexternal icon	May 12, 2020
Loncastuximab tesirine (Zynlonta™)	10:00 Antineoplastic Agents	DailyMedexternal icon	May 28, 2021
melphalan flufenamide (Pepaxto®)	10:00 Antineoplastic Agents	DailyMedexternal icon	May 28, 2021
belantamab mafodotin (Blenrep)	10:00 Antineoplastic Agents	DailyMedexternal icon	May 28, 2021
tisotumab vedotin-tftv (Tivdak™)	10:00 Antineoplastic Agents	DailyMedexternal icon	March 23, 2022

January 10th, 2019
NIOSH has determined it is unlikely that risperidone (Risperidal®) poses a carcinogenic, reproductive, or developmental hazard to workers in a healthcare setting and is no longer considered a hazardous drug by NIOSH.

January 10th, 2019
NIOSH has determined it is unlikely that paliperidone (Invega®) poses a carcinogenic, reproductive or developmental hazard to workers in a healthcare setting and is no longer considered a hazardous drug by NIOSH.

April 12, 2017
NIOSH has determined that telavancin (VIBATIV®) does not meet the NIOSH definition of a hazardous drug and is no longer considered a hazardous drug by NIOSH.

Click here for the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016pdf icon.

What has the National Institute for Occupational Safety and Health identified as hazardous drugs?

The NIOSH criteria include : carcinogenicity, teratogenicity, reproductive toxicity, genotoxicity, organ toxicity at low doses, and drugs that mimic existing drugs in structure or toxicity. While the majority of the hazardous drugs are cytotoxic antineoplastic drugs, drugs from other classes are included.

What are the categories of hazardous medications?

DHHS (NIOSH) Publication No. The format for the 2014 list was revised to include three groups of hazardous drugs: (1) Antineoplastic drugs; (2) Non-antineoplastic hazardous drugs; and (3) Drugs with reproductive effects.

Where would you find warnings and special handling for hazardous drugs?

The Pharmacy and Clinic Facility will: Provide access to SDSs for hazardous drugs that it distributes. These SDSs are available by calling the pharmacy that distributed the drug. Provide a warning on the label of hazardous drugs that it distributes, indicating that special handling precautions are necessary.